EKSO (Ekso Bionics Holdings) Total Inventories: $4.65 Mil (As of Mar. 2026)


EKSO Ekso Bionics Holdings Inc EKSO
32 GF Score
Price $11.65
GF Value $4.31
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Ekso Bionics Holdings Total Inventories?

Ekso Bionics Holdings EKSO -0.42% 32 Total Inventories is $4.65 Mil as of Mar. 2026. GuruFocus rates EKSO with a GF Score™ of 32/100 and a GF Value™ of $4.31 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Ekso Bionics Holdings's total inventories for the quarter that ended in Mar. 2026 was $4.65 Mil. Ekso Bionics Holdings's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was $4.74 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Ekso Bionics Holdings's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was $-2.21.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Ekso Bionics Holdings's Days Inventory for the three months ended in Mar. 2026 was 404.98.

Inventory Turnover measures how fast the company turns over its inventory within a year. Ekso Bionics Holdings's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.23.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Ekso Bionics Holdings's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 2.21.

Ekso Bionics Holdings  (NAS:EKSO) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Ekso Bionics Holdings's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is

Net-Net Working Capital Per Share (Q: Mar. 2026 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(3.993+0.75 * 4.537+0.5 * 4.649-13.928
-3.65-0)/3.563
=-2.21

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Ekso Bionics Holdings's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2026 )/Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=4.7355/1.067*365 / 4
=404.98

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Ekso Bionics Holdings's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2026 ) / Average Total Inventories (Q: Mar. 2026 )
=1.067 / 4.7355
=0.23

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Ekso Bionics Holdings's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=4.7355 / 2.141
=2.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Ekso Bionics Holdings Total Inventories Related Terms

Ekso Bionics Holdings Total Inventories Historical Data

* Premium members only.

The historical data trend for Ekso Bionics Holdings's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ekso Bionics Holdings Total Inventories Chart

Ekso Bionics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.24 5.19 5.05 4.57 4.82

Ekso Bionics Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.96 5.44 5.02 4.82 4.65
EKSO
32GF Score
Ekso Bionics Holdings Inc EKSO
Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ekso Bionics Holdings Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of $4.65 Mil mean?
Ekso Bionics Holdings (EKSO) has a Total Inventories of $4.65 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Ekso Bionics Holdings and its competitors.
Is Ekso Bionics Holdings' Total Inventories too high?
Ekso Bionics Holdings' current Total Inventories is $4.65 Mil. Overall, Ekso Bionics Holdings has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ekso Bionics Holdings' Total Inventories compare to POCI and HBIO?
Ekso Bionics Holdings' Total Inventories of $4.65 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Devices & Instruments company?
A good Total Inventories depends on the Medical Devices & Instruments industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Ekso Bionics Holdings and its competitors. Ekso Bionics Holdings's current Total Inventories is $4.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ekso Bionics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ekso Bionics Holdings (EKSO) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.31, compared to a current price of $11.65 — trading 170.3% above its estimated fair value. The current Total Inventories is $4.65 Mil. Ekso Bionics Holdings' overall GF Score™ is 32/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Ekso Bionics Holdings (EKSO), the current Total Inventories is $4.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ekso Bionics Holdings (EKSO) Overvalued in 2026?

Based on GuruFocus' analysis, Ekso Bionics Holdings stock appears to be overvalued. The current stock price of $11.65 is trading 170.3% above its estimated GF Value™ of $4.31. GuruFocus considers Ekso Bionics Holdings to be Significantly Overvalued.

Key valuation signals for EKSO:

  • Total Inventories: $4.65 Mil
  • GF Value™: $4.31 vs. price of $11.65 (170.3% above fair value)
  • GF Score™: 32/100 with 10 warning signs

No single metric tells the full story. See the EKSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ekso Bionics Holdings Business Description

Address 101 Glacier Point, Suite A, San Rafael, CA, USA, 94901
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
32GF Score

Get the complete analysis for EKSO

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.65
Price
$4.31
GF Value